GENE ONLINE|News &
Opinion
Blog

Chemotherapy
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Novel Technique to Deliver Chemotherapy Drug into Human Brains
2023-05-09
EMA Accepts Daiichi Sankyo’s Marketing Application For Leukemia Drug
2022-08-24
China’s InxMed Raises $50 Million to Inhibit Cancer-Resisting FAKs
2022-03-07
EC Approves New Indication for Teysuno to Address Hand-Foot Syndrome and Cardiotoxicity
2022-02-07
Day 2 ASCO 2021 Roundup: Focus on Equity in Cancer Care, Highlights from Breast Cancer and Gastrointestinal Cancer Studies
2021-06-06
BMS’s Drug Bags First FDA-Approved Immunotherapy Tag for Initial Treatment of Gastric Cancer
2021-04-19
Scientists Engineer Immune Cells with Cytokine to Stop Cancer Spread
2021-03-26
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
2021-03-20
G1 Therapeutics’ Drug Reduces Chemo Related Side Effects, Nabs FDA OK
2021-02-16
FDA Approves Treatment for Aggressive Form of Mesothelioma After Sixteen Long Years
2020-10-04
R&D
Merck Bets Big on Seattle Genetics for Two Oncology Drugs
2020-09-16
BIO Asia-Taiwan 2020: Nobel Laureate Prof. Tasuku Honjo Reflects on the Future of Cancer Immunotherapy
2020-07-22Partner
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
1 2 3
LATEST
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
Scroll to Top